PowderJect signs research deals for needle-less vaccines
This article was originally published in Clinica
Drug delivery company PowderJect has formed research agreements with Zeneca and an unnamed Japanese company to study the delivery of drugs using its needle-less injection system. The UK company's product uses a helium jet to shoot drug particles through the skin and injects powder instead of liquid.
You may also be interested in...
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.